CZ2001655A3 - Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby - Google Patents
Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby Download PDFInfo
- Publication number
- CZ2001655A3 CZ2001655A3 CZ2001655A CZ2001655A CZ2001655A3 CZ 2001655 A3 CZ2001655 A3 CZ 2001655A3 CZ 2001655 A CZ2001655 A CZ 2001655A CZ 2001655 A CZ2001655 A CZ 2001655A CZ 2001655 A3 CZ2001655 A3 CZ 2001655A3
- Authority
- CZ
- Czechia
- Prior art keywords
- amino acid
- peptide
- hydrophobic amino
- acid
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9835998P | 1998-08-28 | 1998-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ2001655A3 true CZ2001655A3 (cs) | 2001-11-14 |
Family
ID=22268937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ2001655A CZ2001655A3 (cs) | 1998-08-28 | 1999-08-20 | Cyklický peptid, prostředek, způsob indukce myelinizace, způsob potlačení degenerace neuronů a způsob léčby |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1105420A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP4528443B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20010079695A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1324367A (cg-RX-API-DMAC10.html) |
| AU (1) | AU751034B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9913490A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2341810A1 (cg-RX-API-DMAC10.html) |
| CZ (1) | CZ2001655A3 (cg-RX-API-DMAC10.html) |
| HU (1) | HUP0103265A3 (cg-RX-API-DMAC10.html) |
| IL (1) | IL141586A0 (cg-RX-API-DMAC10.html) |
| PL (1) | PL204359B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2000012553A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA200102489B (cg-RX-API-DMAC10.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| WO2000012553A1 (en) * | 1998-08-28 | 2000-03-09 | Myelos Corporation | Cyclic prosaposin-derived peptides and uses thereof |
| AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
| IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
| CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
| CN101583346B (zh) | 2006-04-28 | 2015-08-19 | 儿童医院医疗中心 | 用于穿膜药物递送系统的皂化蛋白c和相关蛋白及肽的促融合性质 |
| CA2666953A1 (en) * | 2006-10-20 | 2008-05-02 | Children's Hospital Medical Center | Spontaneous forming ellipsoidal phospholipid unilamellar vesicles |
| CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
| US11291616B2 (en) | 2015-04-23 | 2022-04-05 | The Procter And Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
| BR112018067494B1 (pt) | 2016-03-03 | 2022-05-10 | The Procter & Gamble Company | Composição anticaspa em aerossol |
| EP3528774A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam designating hair volume benefits |
| JP6952768B2 (ja) | 2016-10-21 | 2021-10-20 | ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ | 低粘度であり粘度低減剤を含む、安定なコンパクトシャンプー製品 |
| EP3528896A1 (en) | 2016-10-21 | 2019-08-28 | The Procter & Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
| US11154467B2 (en) | 2016-10-21 | 2021-10-26 | The Procter And Gamble Plaza | Concentrated shampoo dosage of foam designating hair conditioning benefits |
| EP3528897A1 (en) | 2016-10-21 | 2019-08-28 | The Procter & Gamble Company | Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space |
| EP3528894A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
| CN109862944A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型 |
| US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
| US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
| US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
| EP4400092A3 (en) | 2017-10-10 | 2024-10-16 | The Procter & Gamble Company | Compact shampoo composition with amino acid based anionic surfactants and cationic polymers |
| US10426713B2 (en) | 2017-10-10 | 2019-10-01 | The Procter And Gamble Company | Method of treating hair or skin with a personal care composition in a foam form |
| JP6974928B2 (ja) | 2017-10-10 | 2021-12-01 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | コンパクトなシャンプー組成物 |
| WO2019074989A1 (en) | 2017-10-10 | 2019-04-18 | The Procter & Gamble Company | COMPACT SHAMPOO COMPOSITION CONTAINING SULFATE-FREE SURFACTANTS |
| CN111556743B (zh) | 2017-12-20 | 2023-07-18 | 宝洁公司 | 包含硅氧烷聚合物的澄清洗发剂组合物 |
| EP3813774A1 (en) | 2018-06-29 | 2021-05-05 | The Procter & Gamble Company | Low surfactant aerosol antidandruff composition |
| US12226505B2 (en) | 2018-10-25 | 2025-02-18 | The Procter & Gamble Company | Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents |
| WO2021113583A1 (en) | 2019-12-06 | 2021-06-10 | The Procter & Gamble Company | Sulfate free composition with enhanced deposition of scalp active |
| WO2021173203A1 (en) | 2020-02-27 | 2021-09-02 | The Procter & Gamble Company | Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics |
| WO2022109094A1 (en) | 2020-11-23 | 2022-05-27 | The Procter & Gamble Company | Personal care compositions free of sulfated surfactants |
| JP7768985B2 (ja) | 2020-12-04 | 2025-11-12 | ザ プロクター アンド ギャンブル カンパニー | 悪臭低減物質を含むヘアケア組成物 |
| US12409125B2 (en) | 2021-05-14 | 2025-09-09 | The Procter & Gamble Company | Shampoo compositions containing a sulfate-free surfactant system and sclerotium gum thickener |
| US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
| CA3235522A1 (en) | 2021-12-09 | 2023-06-15 | The Procter & Gamble Company | Sulfate free personal cleansing composition comprising effective preservation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL106106A0 (en) * | 1993-06-22 | 1993-10-20 | Interpharm Lab Ltd | Library of polymeric molecules and its preparation |
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| WO2000012553A1 (en) * | 1998-08-28 | 2000-03-09 | Myelos Corporation | Cyclic prosaposin-derived peptides and uses thereof |
-
1999
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Ceased
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Withdrawn
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2341810A1 (en) | 2000-03-09 |
| ZA200102489B (en) | 2002-06-04 |
| PL346346A1 (en) | 2002-02-11 |
| WO2000012553A1 (en) | 2000-03-09 |
| PL204359B1 (pl) | 2010-01-29 |
| AU751034B2 (en) | 2002-08-08 |
| KR20010079695A (ko) | 2001-08-22 |
| JP2002523518A (ja) | 2002-07-30 |
| CN1324367A (zh) | 2001-11-28 |
| EP1105420A1 (en) | 2001-06-13 |
| JP4528443B2 (ja) | 2010-08-18 |
| HUP0103265A3 (en) | 2002-09-30 |
| HUP0103265A2 (hu) | 2002-02-28 |
| BR9913490A (pt) | 2001-09-25 |
| IL141586A0 (en) | 2002-03-10 |
| AU5690599A (en) | 2000-03-21 |
| JP2010150272A (ja) | 2010-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU751034B2 (en) | Cyclic prosaposin-derived peptides and uses thereof | |
| RU2266129C2 (ru) | Способ воздействия на нейродегенеративное нарушение или нарушение миелинизации | |
| WO1997015593A1 (en) | Neurotrophin antagonists | |
| AU751161B2 (en) | Retro-inverso neurotrophic and analgesic peptides | |
| US6849602B1 (en) | Compositions for alleviating neuropathic pain with prosaposin receptor agonists | |
| CA2282827A1 (en) | Method of alleviating neuropathic pain | |
| WO1998042746A9 (en) | Synthetic saposin c-derived neurotrophic peptides | |
| AU7795698A (en) | Synthetic saposin c-derived neurotrophic peptides | |
| US20020128193A1 (en) | Retro-inverso prosaposin-derived peptides and use thereof | |
| MXPA01001966A (en) | Cyclic prosaposin-derived peptides and uses thereof | |
| AU2002300005B2 (en) | Method of alleviating neuropathic pain | |
| AU4267297A (en) | Method of alleviating neuropathic pain | |
| MXPA98007245A (en) | Methods to alleviate neuropathic pain using peptides derived from prosapos |